Jianfeng Group Lin2016 -029 (Announcement on Progress of Subsidiary's Foreign Investment)
Release time:
2020-08-05
Securities Code: 600668 Securities Abbreviation: Jianfeng Group No.: Pro 2016-029
Bond Abbreviation: 13 Peak 01 Bond Code: 122227
Bond Abbreviation: 13 Peak 02 Bond Code: 122344
Zhejiang Jianfeng Group Co., Ltd.
Announcement on Progress of Subsidiary's Foreign Investment
The Board of Directors and all directors of the Company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and assumes individual and joint responsibility for the truthfulness, accuracy and completeness of its contents .
Basic Information on Foreign Investment in 1.
On July 12, 2016 , Zhejiang Jianfeng Pharmaceutical Co., Ltd. (hereinafter referred to as "Jianfeng Pharmaceutical"), a subsidiary of the Company, and Germany Gefu Pharmaceutical Co., Ltd. (hereinafter referred to as "Gefu Pharmaceutical"), Zhuhai Hengqin Deyunjia International Trade Co., Ltd. (hereinafter referred to: de Yunjia) signed the "Sino-foreign Joint Venture Contract" and jointly funded the establishment of a Sino-foreign joint venture in Jinhua City, Zhejiang Province, China, committed to building a pharmaceutical company for infants and children. The Chinese name of the joint venture company is: Zhejiang Jindel Baby Pharmaceutical Co., Ltd. The registered capital of the joint venture company is RMB 20 million, of which: Jianfeng Pharmaceutical contributed RMB 11 million in cash, Ge Fu Pharmaceutical contributed RMB 5 million in the evaluation of intellectual property rights of proprietary technology, and Deyunjia contributed RMB 4 million in cash.
For details, please refer to 2016 -Lin 2016-026 "Announcement on Foreign Investment of Subsidiaries" published by the company in the designated information disclosure media "shanghai securities news", "china securities journal" and the website of Shanghai Stock Exchange (www.sse.com.cn ) on July 13, 40.
Progress of 2. Foreign InvestmentAfter the signing of the Sino-Foreign Joint Venture Contract, the parties to the cooperation have applied to the relevant departments in accordance with relevant national laws, regulations and relevant government regulations and obtained the Approval Certificate for the People's Republic of China Foreign-invested Enterprises and the Business License.
The main registration items of the "Business License" are as follows:
Name: Zhejiang Jindel Baby Drug Co., Ltd.
Unified Social Credit Code: 91330700MA28E8DU4L
Type: Limited Liability Company (
Sino-foreign Joint Venture)
Domicile: legal Representative of, 3rd Floor, X02 Office Quality Inspection Building, No. 58
, Gaofan Section, Tangxi Town, Wucheng District, Jinhua City, Zhejiang Province: Jiang XiaomengRegistered Capital: RMB 20 Million Yuan
Date of Establishment: August 30, 2016
Business Term: 2016
from August 30 to August 29, 2046
Scope of business: drug research and development, drug production (see "Drug Production License" for the specific scope), drug business (see "Drug Business License" for the specific scope), import and export of health products. (For projects subject to approval according to law, business activities can only be carried out after approval by relevant departments)As of the date of this announcement, the cooperating parties have not yet made capital contributions.
3. Reference Document
Copy of Business License of Zhejiang Jindal Baby Pharmaceutical Co., Ltd. and Approval Certificate of the People's Republic of China Foreign Investment Enterprise.
hereby announce
Zhejiang Jianfeng Group Co., Ltd. Board of Directors
September 2, 2016
More information
The company won the Taurus Award
On December 29, 2022, the "2022 High-quality Development Forum of listed companies and the 24th Golden Bull Award presentation ceremony of listed companies" jointly sponsored by China Securities News, Haikou Municipal Government and Haikou National High-tech Zone was held in Haikou. The list of Golden Bull Awards of listed companies was officially announced. With its outstanding performance, Jianfeng Group won the "2021 Golden Bull Most Investment Value Award".
2023
01-12
From December 11th to 12th, the 13th National Congress of the All-China Federation of Industry and Commerce was held in Beijing. Jiang Xiaomeng, chairman of the group company, attended the conference as a representative of Zhejiang.
2022
12-22
Yunnan Jianfeng won the title of "Harmonious Labor Relations Enterprise" in Yunnan Province
On November 18, the Yunnan Provincial Federation of Trade Unions, the Department of Human Resources and Social Security, the Entrepreneur Association and other units jointly issued a document to commend the harmonious labor relations enterprises in Yunnan Province from 2020 to 2021. Yunnan Jianfeng Cement Company is on the list and is the only enterprise in the urban area of Pu'er to receive this honor.
2022
12-13
Huang Ping Jianfeng won the title of "provincial green factory" in Guizhou
On November 30, the Guizhou Provincial Department of Industry and Information Technology released the 2022 list of green manufacturing units in Guizhou Province, and Huangping Jianfeng Cement Company was recognized as a "provincial green factory".
2022
12-13
On December 2, Yu Jianhong, general manager of the group company, gave a management lesson to the company's reserve management talents under the title of "Enterprise Management Innovation in Great Changes.
2022
12-13
On November 24, Jiang Xiaomeng, secretary of the party committee and chairman of the group company, gave a special party lesson to all party members and cadres of the company under the title of "comprehensively promoting the Great Rejuvenation of the Chinese Nation with Chinese Modernization" to interpret and preach the spirit of the 20th CPC National Congress.
2022
12-04